A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

Nature Genetics

Volumn 32, Issue 4, 2002, Pages 666-669

  Prokunina, Ludmila ^a,b   Castillejo López, Casimiro ^c   Öberg, Fredrik ^a   Gunnarsson, Iva ^d   Berg, Louise ^e   Magnusson, Veronica ^a   Brookes, Anthony J ^f   Tentler, Dmitry ^a   Kristjansdóttir, Helga ^g   Gróndal, Gerdur ^g   Isine Bolstad, Anne ^h,i   Svenungsson, Elisabet ^d   Lundberg, Ingrid ^d   Sturfelt, Gunnar ^j   Jönssen, Andreas ^j   Truedsson, Lennart ^k   Lima, Guadalupe ^l   Alcocer Varela, Jorge ^l   Jonsson, Roland ^h   Gyllensten, Ulf B ^a   Harley, John B ^m   Alarcón Segovia, Donato ^l   Steinsson, Kristján ^g   Alarcón Riquelme, Marta E ^a,b   more..

^a UPPSALA UNIVERSITY   (Sweden)

^b Everygene AB   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Unit of Rheumatology   (Sweden)

^e Ctr for Microbiology Tumor Biology   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Center for Rheumatology Research   (Iceland)

^h UNIVERSITY OF BERGEN   (Norway)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j Department of Rheumatology ^*  (Sweden)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

^l INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^m UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ALLELE; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; ENHANCER REGION; ETHNIC GROUP; FAMILY STUDY; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PDCD1 GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

3' UNTRANSLATED REGIONS; ALLELES; AMINO ACID SUBSTITUTION; ANTIGENS, CD; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL EXTRACTS; CELL NUCLEUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LINKAGE DISEQUILIBRIUM; LOD SCORE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TANDEM REPEAT SEQUENCES; TRANSCRIPTION FACTORS;

EID: 13244277850     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1020     Document Type: Article

References (29)

1. Gudmundsson, S. & Steinsson, K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J. Rheumatol. 17, 1162-1167 (1990).
2. Lawrence, R.C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41, 778-799 (1998).
3. Stahl-Hallengren, C., Jönsen, A., Nived, O. & Sturfelt, G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J. Rheumatol. 27, 685-691 (2000).
4. Arnett, F.C. & Reveille, J.D. Genetics of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 18, 865-892 (1992).
5. Moser, K.L. et al. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl Acad. Sci. USA 95, 14869-14874 (1998).
6. Gaffney, P.M. et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl Acad. Sci. USA 95, 14875-14879 (1998).
7. Gaffney, P.M. et al. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am. J. Hum. Genet. 66, 547-566 (2000).
8. Shai, R. et al. Genome-wide screen for systemic lupuserythematosus susceptibility genes in multiplex families. Hum. Mol. Genet. 8, 639-644 (1999).
9. Lindqvist, A.K. et al. A susceptibility locus for systemic lupus erythematosus (hSLE1) in chromosome 2q. J. Autoimmun. 14, 169-178 (2000).
10. Magnusson, V. et al. Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 70, 307-314 (2000).
11. Shinohara, T., Taniwaki, M., Ishida, Y., Kawaichi M. & Honjo, T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 23, 704-706 (1994).
12. Finger, L.R. et al. The human PD-1 gene: Complete eDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene 197, 177-187 (1997).
13. Vibhakar, R., Juan, G., Traganos, F., Darzynkiewicz, Z. & Finger, L.R. Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp. Cell Res. 232, 25-28 (1997).
14. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupuslike autoimmune diseases by disruption ofthe PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
15. Thomson, G. Mapping disease genes: Family-based association studies. Am. J. Hum. Genet. 57, 487-498 (1995).
16. Lutterbach, B. & Hiebert, S.W. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245, 223-235 (2000).
17. Wong, H.K., Kammer, G.M., Dennis, G. & Tsokos, G.C. Abnormal NF-K B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J. Immunol. 163, 1682-1689 (1999).
18. Nishimura, H. & Honjo, T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22, 265-268 (2001).
19. Goodnow, C.C. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet357, 2115-2121 (2001).
20. Hugot, J.P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
21. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
22. Tan, E.M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271-1277 (1982).
23. Lichter, P., Cremer, T., Borden, J., Manuelidis, L. & Ward, D.C. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80, 224-234 (1988).
24. Howell, W.M., Jobs, M., Gyllensten, U. & Brookes, A.J. Dynamic allele-specific hybridization (D.A.S.H.). Nature Biotechnol. 17, 87-88 (1999).
25. , Prince, J.A. et al. Robust and accurate single-nucleotide polymorphism genotyping by dynamic allele-specific hybridization (D.A.S.H.): Design criteria and assay validation. Genome Res. 11, 152-162 (2001).
26. Andrews, N.C. & Faller, D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499 (1991).
27. Bombardier, C., Gladman, D.D., Urowitz, M.B., Caron, D. & Chang, C.H. Derivation of the SLEDAI - A disease activity index for lupus patients. Arthritis Rheum. 35, 630-640 (1992).
28. Lathrop, M. Estimating genotype relative risk. Tissue Antigens 22, 160-166 (1983).
29. Martin, E.R., Monks, S.A, Warren, L.L. & Kaplan, N.L. The pedigree disequilibrium test. Am. J. Hum. Genet. 67, 146-154 (2000).